Bright Minds Biosciences News

Bright Minds Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ian McDonald(30.56%)

Feb 26 20:22 ET

Bright Minds Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ian McDonald(8.88%)

Feb 26 20:12 ET

Bright Minds Biosciences | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 13 06:04 ET

Bright Minds Biosciences | SC 13D: Statement of acquisition of beneficial ownership by individuals-Ian McDonald(7.57%)

Jan 18 00:00 ET

Bright Minds Biosciences: FY2023 Annual Report

Dec 29, 2023 00:00 ET

Bright Minds Biosciences | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 26, 2023 00:00 ET

Bright Minds Biosciences | 6-K: Bright Minds Announces Non-Brokered Private Placement Fully Subscribed By Management

Dec 8, 2023 06:00 ET

Bright Minds Biosciences | 6-K: Condensed Consolidated Interim Financial Statements for the three and nine months ended June 30, 2023 and 2022

Aug 14, 2023 19:07 ET

Bright Minds Biosciences | 6-K: Bright Minds Biosciences Announces Positive qEEG Data from its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Aug 8, 2023 16:24 ET

Bright Minds Biosciences | 6-K: Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Jul 20, 2023 13:49 ET

Bright Minds Biosciences | 6-K: Bright Minds Announces Effective Date of Share Consolidation

Jul 12, 2023 16:55 ET

Bright Minds Biosciences | 6-K: Bright Minds Announces Proposed Share Consolidation

Jun 22, 2023 15:36 ET

Bright Minds Biosciences | 6-K: MANAGEMENT'S DISCUSSION AND ANALYSIS FOR THE SECOND QUARTER ENDED MARCH 31, 2023

May 15, 2023 17:15 ET

Bright Minds Biosciences | 6-K: Bright Minds Biosciences Receives a Favorable Written Opinion from the International Searching Authority for BMB-202

Apr 19, 2023 15:41 ET

Bright Minds Biosciences | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

Apr 10, 2023 08:15 ET

Bright Minds Biosciences | 6-K: Bright Minds Biosciences to Hold Annual General Meeting on March 24, 2023

Mar 2, 2023 14:37 ET

Bright Minds Biosciences | 6-K: Bright Minds Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023

Feb 27, 2023 17:20 ET

Bright Minds Biosciences | 6-K: Bright Minds Biosciences Announces Non-Executive Director Appointment

Feb 17, 2023 14:28 ET

Bright Minds Biosciences | 6-K: BRIGHT MINDS BIOSCIENCES ANNOUNCES RECEIPT OF NASDAQ DEFICIENCY LETTER REGARDING INDEPENDENT DIRECTOR AND AUDIT COMMITTEE REQUIREMENTS

Feb 8, 2023 17:24 ET

Bright Minds Biosciences | 6-K: Condensed Consolidated Interim Financial Statements and Management's Discussion and Analysis

Feb 7, 2023 17:15 ET